Published in Nature on May 14, 1998
Cocaine: history, use, abuse. J R Soc Med (1999) 0.77
How practical are recommendations for dietary control in phenylketonuria? Lancet (2002) 2.82
DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science (1998) 2.53
Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell (1994) 2.46
Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons. J Neurosci (2000) 1.94
D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications. Synapse (1987) 1.69
Loss of autoreceptor functions in mice lacking the dopamine transporter. Nat Neurosci (1999) 1.65
Increased responsiveness of ventral tegmental area dopamine neurons to glutamate after repeated administration of cocaine or amphetamine is transient and selectively involves AMPA receptors. J Pharmacol Exp Ther (1997) 1.61
Whole-cell plasticity in cocaine withdrawal: reduced sodium currents in nucleus accumbens neurons. J Neurosci (1998) 1.50
Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: studies in the ventral tegmental area. J Neurosci (1988) 1.49
Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology (2001) 1.46
Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron (1997) 1.44
Excitability of dopamine neurons: modulation and physiological consequences. CNS Neurol Disord Drug Targets (2006) 1.30
Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration. J Pharmacol Exp Ther (1989) 1.22
Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations. Synapse (1999) 1.18
Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. J Pharmacol Exp Ther (1991) 1.17
Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice. J Neurosci (1998) 1.17
Electrophysiological evidence for the existence of both D-1 and D-2 dopamine receptors in the rat nucleus accumbens. J Neurosci (1986) 1.16
Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science (1983) 1.16
Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: microiontophoretic studies. J Pharmacol Exp Ther (1984) 1.15
The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons. J Neurosci (1995) 1.08
Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine. Psychopharmacology (Berl) (1997) 1.07
Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J Pharmacol Exp Ther (1993) 1.06
Strategies for the treatment of cystathionine beta-synthase deficiency: the experience of the Willink Biochemical Genetics Unit over the past 30 years. Eur J Pediatr (1998) 1.02
MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. J Neurosci (1994) 1.00
Electrophysiological evidence for A10 dopamine autoreceptor subsensitivity following chronic D-amphetamine treatment. Brain Res (1984) 0.97
Transient fungemia due to Candida lusitaniae. South Med J (1985) 0.96
Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors. Synapse (1989) 0.94
Dopamine enhances glutamate-induced excitation of rat striatal neurons by cooperative activation of D1 and D2 class receptors. Neurosci Lett (1997) 0.93
A10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonists. Life Sci (1984) 0.93
Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat. Life Sci (1983) 0.91
Altered responsiveness of medial prefrontal cortex neurons to glutamate and dopamine after withdrawal from repeated amphetamine treatment. Synapse (2000) 0.91
Glutamate receptor regulation of rat nucleus accumbens neurons in vivo. Synapse (1996) 0.91
Defining subgroup size in fission-fusion societies. Folia Primatol (Basel) (1993) 0.89
Relationship between D1 dopamine receptors, adenylate cyclase, and the electrophysiological responses of rat nucleus accumbens neurons. J Neural Transm Gen Sect (1991) 0.89
D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems. Synapse (1989) 0.89
Popliteal vein thrombosis associated with femoral osteochondroma and popliteal artery pseudoaneurysm. Postgrad Med J (1995) 0.89
Maternal recognition of pregnancy signal or endocrine disruptor: the two faces of oestrogen during establishment of pregnancy in the pig. Soc Reprod Fertil Suppl (2006) 0.88
Increased risk of vitamin B12 deficiency in patients with phenylketonuria on an unrestricted or relaxed diet. J Pediatr (2000) 0.87
A10 somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment. Neurosci Lett (1990) 0.87
Adaptations in the mesoaccumbens dopamine system resulting from repeated administration of dopamine D1 and D2 receptor-selective agonists: relevance to cocaine sensitization. Psychopharmacology (Berl) (1998) 0.84
Dietary practices in pyridoxine non-responsive homocystinuria: a European survey. Mol Genet Metab (2013) 0.84
Pharmacological reversal of behavioral and cellular indices of cocaine sensitization in the rat. Psychopharmacology (Berl) (2000) 0.83
Dopamine D3 receptor mutant and wild-type mice exhibit identical responses to putative D3 receptor-selective agonists and antagonists. Synapse (1999) 0.83
Effects of body condition score at parturition and postpartum protein supplementation on estrous behavior and size of the dominant follicle in beef cows. J Anim Sci (2008) 0.83
Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies. J Pharmacol Exp Ther (1988) 0.82
Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat. Psychopharmacology (Berl) (1992) 0.82
Inhibition of non-dopamine cells in the ventral tegmental area by benzodiazepines: relationship to A10 dopamine cell activity. Eur J Pharmacol (1987) 0.82
Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog. J Clin Invest (1989) 0.82
Behavioral and biochemical evidence for serotonergic actions of tetrahydro-beta-carbolines. Life Sci (1982) 0.82
Dietary management of urea cycle disorders: European practice. Mol Genet Metab (2013) 0.82
Dopamine receptor antagonists prevent expression, but not development, of morphine sensitization. Eur J Pharmacol (1995) 0.81
Acute depolarization block of A10 dopamine neurons: interactions of morphine with dopamine antagonists. Brain Res (1992) 0.81
MK-801 prevents the development of behavioral sensitization during repeated morphine administration. Synapse (1994) 0.81
The dopamine D1 receptor antagonist SCH 23390 can exert D1 agonist-like effects on rat nucleus accumbens neurons. Neurosci Lett (1995) 0.81
The expression of cocaine sensitization is not prevented by MK-801 or ibotenic acid lesions of the medial prefrontal cortex. Behav Brain Res (1999) 0.81
Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery. Thromb Haemost (1997) 0.81
Changes in behavior in free-ranging Lemur catta following release in a natural habitat. Am J Primatol (1999) 0.81
Randomised controlled trial of essential fatty acid supplementation in phenylketonuria. Eur J Clin Nutr (2006) 0.80
Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies. Synapse (1994) 0.80
L-type calcium channels modulate glutamate-driven bursting activity in the nucleus accumbens in vivo. Brain Res (2000) 0.80
D-1 dopamine receptor stimulation enables the inhibition of nucleus accumbens neurons by a D-2 receptor agonist. Eur J Pharmacol (1987) 0.80
Electrophysiological correlates of psychomotor stimulant-induced sensitization. Ann N Y Acad Sci (1992) 0.80
The discriminative stimulus properties of LSD: mechanisms of action. Neuropharmacology (1978) 0.79
Discriminative stimulus properties of phencyclidine. Neuropharmacology (1979) 0.79
Training dose as a factor in LSD-saline discrimination. Psychopharmacology (Berl) (1982) 0.79
Influence of body condition at calving and postpartum nutrition on endocrine function and reproductive performance of primiparous beef cows. J Anim Sci (2003) 0.79
Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons. Brain Res (1984) 0.78
Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions. Science (1982) 0.78
Influence of nutrient intake and body fat on concentrations of insulin-like growth factor-I, insulin, thyroxine, and leptin in plasma of gestating beef cows. J Anim Sci (2005) 0.78
Comparison of the effects of LSD and lisuride on A10 dopamine neurons in the rat. Neuropharmacology (1983) 0.78
A neuropharmacological analysis of the discriminative stimulus properties of fenfluramine. Psychopharmacology (Berl) (1981) 0.78
B-HT 920 stimulates postsynaptic D2 dopamine receptors in the normal rat: electrophysiological and behavioral evidence. Life Sci (1988) 0.77
Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum. Neuroscience (1992) 0.77
Dietary management of urea cycle disorders: UK practice. J Hum Nutr Diet (2012) 0.77
The effect of serotonin depletion on the discriminability of LSD. Pharmacol Biochem Behav (1980) 0.77
MK-801 does not prevent acute stimulatory effects of amphetamine or cocaine on locomotor activity or extracellular dopamine levels in rat nucleus accumbens. Brain Res (1994) 0.77
Discriminable stimuli produced by hallucinogens. Psychopharmacol Commun (1976) 0.76
Lack of specificity of an animal behavior model for hallucinogenic drug action. Pharmacol Biochem Behav (1981) 0.76
Metabolic status, gonadotropin secretion, and ovarian function during acute nutrient restriction of beef heifers. J Anim Sci (2013) 0.76
Dopaminergic and serotonergic mediation of the discriminable effects of ergot alkaloids. Eur J Pharmacol (1982) 0.76
The role of dopamine and serotonin in the discriminative stimulus effects of lisuride. J Pharmacol Exp Ther (1982) 0.76
Decreased activity of rat A10 dopamine neurons following withdrawal from repeated cocaine. Eur J Pharmacol (1992) 0.76
Interactions of cholecystokinin and dopamine in the nucleus accumbens. Ann N Y Acad Sci (1985) 0.76
Effects of grazing program and subsequent finishing on gene expression in different adipose tissue depots in beef steers. J Anim Sci (2005) 0.76
Electrophysiological effects of putative autoreceptor-selective dopamine agonists on A10 dopamine neurons. J Pharmacol Exp Ther (1993) 0.76
The vicious cyclin of addiction. Nat Med (2001) 0.75
Analyzing mechanism(s) of hallucinogenic drug action with drug discrimination procedures. Neurosci Biobehav Rev (1982) 0.75
The inheritance pattern of factor XII (Hageman) deficiency in domestic cats. Can J Comp Med (1980) 0.75
Inhibition of dopamine synthesis in striatal slices by the D1 agonist SKF 38393 is not mediated by D1 dopamine receptors. Synapse (1990) 0.75
Electrophysical analyses of psychostimulant drug actions: from the slice to the awake animal. NIDA Res Monogr (1996) 0.75
Beneficial short-term effects of unprocessed wheat bran on lipid and glucose metabolism in man. Hum Nutr Clin Nutr (1985) 0.75
Neurobiology. Dopamine receptors get a boost. Nature (2001) 0.75
How can I explain why God lets patients suffer? A psychologist responds: listening opens doors. J Christ Nurs (1987) 0.75
Discriminative stimulus properties of quipazine: direct serotonergic mediation. Neuropharmacology (1979) 0.75
Effects of tiaspirone (BMY-13859) and a chemical congener (BMY-13980) on A9 and A10 dopamine neurons in the rat. Neuropharmacology (1986) 0.75
Comparative effects of LSD and lisuride: clues to specific hallucinogenic drug actions. Pharmacol Biochem Behav (1986) 0.75
A genetic approach to study mechanisms of cocaine action. Ann N Y Acad Sci (1996) 0.75
Electrophysiological effects of cholecystokinin: central dopaminergic systems. Prog Clin Biol Res (1985) 0.75
Female social dominance in semi-free-ranging ruffed lemurs (Varecia variegata). Folia Primatol (Basel) (1995) 0.75